An archive of ADCC/CDC-enhanced biobetter antibodies developed by Creative Biolabs' state-of-the-art technology platform.
ADCC-Enhanced antibodies represent a next-generation class of therapeutic antibodies engineered to optimize immune-mediated tumor cell destruction. By leveraging the power of antibody-dependent cellular cytotoxicity (ADCC), these antibodies are specifically designed to engage immune effector cells more effectively, leading to enhanced tumor cell killing.
Advanced Afuco™ Technology for Targeted ADCC Enhancement
Creative Biolabs' innovative Afuco™ platform is at the forefront of glycosylation control, offering the precise modulation of antibody glycosylation profiles. By reducing fucosylation in the Fc region of the antibody, we enhance the interaction between the antibody and the FcγR receptor on immune effector cells, such as natural killer (NK) cells. This increased receptor binding affinity significantly improves the efficiency of ADCC, resulting in more robust immune responses against target cells.
Cutting-Edge DNA Recombinant Technology for High-Yield Production
Our ADCC-Enhanced antibodies are produced using state-of-the-art DNA recombinant technology in CHO cells that lack fucosylation enzymes. This enables the generation of high-purity, non-fucosylated antibodies, which are then purified using affinity chromatography with Protein G, ensuring optimal product quality and consistency.
Enhanced Effector Cell Activation: Reduced fucosylation in the Fc region results in improved binding affinity to FcγR receptors on NK cells, macrophages, and dendritic cells, amplifying ADCC activity.
Superior Antitumor Efficacy: The enhanced ADCC response leads to increased tumor cell lysis, improving therapeutic outcomes in cancer treatment.
Reduced Immune Evasion: These antibodies are engineered to minimize immune escape, providing more durable and effective immune responses.
Customizable Production: We offer tailored solutions based on your therapeutic needs, whether for cancer, infectious diseases, or other immune-related disorders.
Browse our selection of ADCC-enhanced antibodies, designed to provide superior immune-mediated cytotoxicity. If you need a custom solution or have specific therapeutic requirements, our experts are available to collaborate with you and develop the ideal ADCC-enhanced antibody for your clinical or research applications.
Biobetter Antibodies Betting on the Future Creative Biolabs Visit
All products and services are for Research Use Only. Do Not use in humans.